Development asset linked to C4 Therapeutics in public FDA and regional records.
biotech · Multiple Myeloma · Multiple Myeloma (MM) · CCCC
C4 Therapeutics
C4 Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
WATERTOWN, MA, USA HQ
2024 Founded
2 Employees
Public company Type
CCCC · NYSE Ticker
Company details
- Status
- Public
- HQ
- WATERTOWN, MA, USA
- Founded
- 2024
- Employees
- 2
- Programs
- 4
- Drugs
- 1
- Patents
- 24
C4 Therapeutics pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
C4 Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.